Ultragenyx Pharmaceutical
RARE
#3247
Rank
HK$27.22 B
Marketcap
HK$281.73
Share price
-4.26%
Change (1 day)
-23.35%
Change (1 year)

Ultragenyx Pharmaceutical (RARE) - Cash on Hand

Cash on Hand as of December 2024 : HK$4.74 Billion

According to Ultragenyx Pharmaceutical's latest financial reports the company has HK$4.74 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Ultragenyx Pharmaceutical - Cash on Hand chart (from 2012 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31HK$4.73 B5.06%
2023-12-31HK$4.50 B-22.84%
2022-12-31HK$5.84 B1.23%
2021-12-31HK$5.77 B-38.04%
2020-12-31HK$9.31 B58.36%
2019-12-31HK$5.88 B63.39%
2018-12-31HK$3.59 B96.49%
2017-12-31HK$1.83 B-37.85%
2016-12-31HK$2.94 B-12.97%
2015-12-31HK$3.38 B132.91%
2014-12-31HK$1.45 B251.35%
2013-12-31HK$0.41 B-38.05%
2012-12-31HK$0.66 B708.04%
2011-12-31HK$82.67 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
HK$8.85 B 86.50%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$1.94 B-59.03%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$1.12 B-76.27%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$1.85 B-60.99%๐Ÿ‡บ๐Ÿ‡ธ USA